Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many people were admitted to hospital for catheter-associated urinary tract infections in each of the last five years; and what the cost was of treating those people.
Answered by Jane Ellison
The Department does not hold information on the number of people admitted to hospital for a catheter-associated urinary tract infection, urinary tract infection or urinary incontinence.
The following table shows a count of finished admission episodes (FAEs) in the last five years with a primary diagnosis of catheter-associated urinary tract infections.
YEAR | FAEs |
2010-11 | 215 |
2011-12 | 294 |
2012-13 | 447 |
2013-14 | 641 |
2014-15 | 942 |
The following table shows a count of FAEs in the last five years with a primary diagnosis of urinary incontinence in England.
Year | FAEs |
2010-11 | 27,797 |
2011-12 | 26,751 |
2012-13 | 24,938 |
2013-14 | 23,498 |
2014-15 | 20,969 |
The following table shows a count of FAEs in the last five years with a primary diagnosis of urinary tract infection in England
YEAR | FAEs |
2010-11 | 168,581 |
2011-12 | 174,818 |
2012-13 | 184,924 |
2013-14 | 187,594 |
2014-15 | 195,282 |
Source: Hospital episode statistics (HES), Health and social care information centre
Notes:
A finished admission episode (FAE) is the first period of admitted patient care under one consultant within one healthcare provider. FAEs are counted against the year or month in which the admission episode finishes. Admissions do not represent the number of patients, as a person may have more than one admission within the period.
The primary diagnosis provides the main reason why the patient was admitted to hospital.
The costs to the National Health Service of treating people with urinary tract infections and urinary incontinence is not available centrally.
Such information as is available is from reference costs, which are the average unit costs of providing defined services to patients. Reference costs for acute care are published by Healthcare Resource Group (HRG), which are standard groupings of similar treatments that use similar resources. For example, costs relating to kidney or urinary tract interventions are assigned to the same HRGs.
Table: Estimated total costs of kidney or urinary tract interventions and urinary incontinence or other urinary problems reported by NHS trusts and foundation trusts, 2010-11 to 2014-15 (£ millions)
Kidney or urinary tract interventions | Urinary incontinence or other urinary problems | |
2010-11 | 370.5 | 28.2 |
2011-12 | 398.9 | 28.1 |
2012-13 | 432.4 | 27.8 |
2013-14 | 464.8 | 28.3 |
2014-15 | 506.5 | 27.6 |
Source: Reference costs, Department of Health
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many people were diagnosed with urinary incontinence in each clinical commissioning group area in each of the last five years; and what the cost was of treating that condition in each such area in each such year.
Answered by Jane Ellison
The Department does not hold information on the number of people admitted to hospital for urinary incontinence.
A count of finished admission episodes with a primary diagnosis of urinary incontinence, by clinical commissioning group of residence, 2010-11 to 2014-15 is provided in the attached table.
The costs to the National Health Service of treating people with urinary tract infections and urinary incontinence is not available centrally.
Such information as is available is from reference costs, which are the average unit costs of providing defined services to patients. Reference costs for acute care are published by Healthcare Resource Group (HRG), which are standard groupings of similar treatments that use similar resources. For example, costs relating to kidney or urinary tract interventions are assigned to the same HRGs.
Table: Estimated total costs of kidney or urinary tract interventions and urinary incontinence or other urinary problems reported by NHS trusts and foundation trusts, 2010-11 to 2014-15 (£ millions)
Kidney or urinary tract interventions | Urinary incontinence or other urinary problems | |
2010-11 | 370.5 | 28.2 |
2011-12 | 398.9 | 28.1 |
2012-13 | 432.4 | 27.8 |
2013-14 | 464.8 | 28.3 |
2014-15 | 506.5 | 27.6 |
Source: Reference costs, Department of Health
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate his Department has made of the number of people with (a) urinary incontinence and (b) faecal incontinence in England.
Answered by Jane Ellison
NHS England has advised that according to a survey conducted in 2008, there are over 14 million adults who have bladder control problems and 6.5 million with bowel control problems in the United Kingdom.
The Department does not collect information on the number of people living with urinary and faecal incontinence specific to Northern Ireland, Scotland and Wales. This is a matter for devolved administrations.
The Healthcare Quality and Improvement Partnership (2010) established that in order to achieve the best clinical outcomes, continence services have to be integrated across primary and secondary care and care home settings.
They also concluded that ‘there is an urgent need for improved and equitable practice for all people with bladder and bowel problems’ through the development of commissioning frameworks, evidence-based training for health professionals and patient empowerment to increase their expectations of cure.
Improving continence care provision through integrated services brings many benefits including:
- a better quality of life and more independence through finding solutions appropriate to individual needs;
- less reliance on pads and products by using alternative treatments;
- a reduction in admissions to hospitals and care homes;
- fewer complications, such as urinary tract infections, faecal impaction and skin breakdown; and
- a reduction in costs.
NHS England’s Excellence in Continence Care guidance provides a framework that enables commissioners to work in collaboration with providers and others to make a step change to address shortfalls so that safe, dignified, efficient and effective continence care is consistently provided.
This guidance is aimed at commissioners, providers, health and social care staff and as information for the public and has been produced in partnership with patient and public advocates, clinicians and partners from the third sector. The roles of everyone involved in the care of people with continence needs are made clear in the guidance and publication via a launch is planned for ‘Self Care Week’ beginning 16 November. The launch will both raise awareness and promote understanding.
In addition the National Institute for Health and Care Excellence has produced a range of guidance for clinicians to support them in the diagnosis, treatment care and support and people with continence problems e.g. Urinary incontinence in women (September 2013), Faecal incontinence in adults (June 2007), Urinary incontinence in neurological disease: assessment and management (August 2012) and Lower urinary tract symptoms in men: management (May 2010).
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps his Department is taking to improve the quality of care provided for people with incontinence in the UK.
Answered by Jane Ellison
NHS England has advised that according to a survey conducted in 2008, there are over 14 million adults who have bladder control problems and 6.5 million with bowel control problems in the United Kingdom.
The Department does not collect information on the number of people living with urinary and faecal incontinence specific to Northern Ireland, Scotland and Wales. This is a matter for devolved administrations.
The Healthcare Quality and Improvement Partnership (2010) established that in order to achieve the best clinical outcomes, continence services have to be integrated across primary and secondary care and care home settings.
They also concluded that ‘there is an urgent need for improved and equitable practice for all people with bladder and bowel problems’ through the development of commissioning frameworks, evidence-based training for health professionals and patient empowerment to increase their expectations of cure.
Improving continence care provision through integrated services brings many benefits including:
- a better quality of life and more independence through finding solutions appropriate to individual needs;
- less reliance on pads and products by using alternative treatments;
- a reduction in admissions to hospitals and care homes;
- fewer complications, such as urinary tract infections, faecal impaction and skin breakdown; and
- a reduction in costs.
NHS England’s Excellence in Continence Care guidance provides a framework that enables commissioners to work in collaboration with providers and others to make a step change to address shortfalls so that safe, dignified, efficient and effective continence care is consistently provided.
This guidance is aimed at commissioners, providers, health and social care staff and as information for the public and has been produced in partnership with patient and public advocates, clinicians and partners from the third sector. The roles of everyone involved in the care of people with continence needs are made clear in the guidance and publication via a launch is planned for ‘Self Care Week’ beginning 16 November. The launch will both raise awareness and promote understanding.
In addition the National Institute for Health and Care Excellence has produced a range of guidance for clinicians to support them in the diagnosis, treatment care and support and people with continence problems e.g. Urinary incontinence in women (September 2013), Faecal incontinence in adults (June 2007), Urinary incontinence in neurological disease: assessment and management (August 2012) and Lower urinary tract symptoms in men: management (May 2010).
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what progress his Department has made on raising awareness and promoting understanding of incontinence amongst (a) health and social care staff and (b) the general public; and if he will make a statement.
Answered by Jane Ellison
NHS England has advised that according to a survey conducted in 2008, there are over 14 million adults who have bladder control problems and 6.5 million with bowel control problems in the United Kingdom.
The Department does not collect information on the number of people living with urinary and faecal incontinence specific to Northern Ireland, Scotland and Wales. This is a matter for devolved administrations.
The Healthcare Quality and Improvement Partnership (2010) established that in order to achieve the best clinical outcomes, continence services have to be integrated across primary and secondary care and care home settings.
They also concluded that ‘there is an urgent need for improved and equitable practice for all people with bladder and bowel problems’ through the development of commissioning frameworks, evidence-based training for health professionals and patient empowerment to increase their expectations of cure.
Improving continence care provision through integrated services brings many benefits including:
- a better quality of life and more independence through finding solutions appropriate to individual needs;
- less reliance on pads and products by using alternative treatments;
- a reduction in admissions to hospitals and care homes;
- fewer complications, such as urinary tract infections, faecal impaction and skin breakdown; and
- a reduction in costs.
NHS England’s Excellence in Continence Care guidance provides a framework that enables commissioners to work in collaboration with providers and others to make a step change to address shortfalls so that safe, dignified, efficient and effective continence care is consistently provided.
This guidance is aimed at commissioners, providers, health and social care staff and as information for the public and has been produced in partnership with patient and public advocates, clinicians and partners from the third sector. The roles of everyone involved in the care of people with continence needs are made clear in the guidance and publication via a launch is planned for ‘Self Care Week’ beginning 16 November. The launch will both raise awareness and promote understanding.
In addition the National Institute for Health and Care Excellence has produced a range of guidance for clinicians to support them in the diagnosis, treatment care and support and people with continence problems e.g. Urinary incontinence in women (September 2013), Faecal incontinence in adults (June 2007), Urinary incontinence in neurological disease: assessment and management (August 2012) and Lower urinary tract symptoms in men: management (May 2010).
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what estimate his Department has made of the number of people living with (a) urinary incontinence and (b) faecal incontinence in (i) Northern Ireland, (ii) Scotland and (iii) Wales.
Answered by Jane Ellison
NHS England has advised that according to a survey conducted in 2008, there are over 14 million adults who have bladder control problems and 6.5 million with bowel control problems in the United Kingdom.
The Department does not collect information on the number of people living with urinary and faecal incontinence specific to Northern Ireland, Scotland and Wales. This is a matter for devolved administrations.
The Healthcare Quality and Improvement Partnership (2010) established that in order to achieve the best clinical outcomes, continence services have to be integrated across primary and secondary care and care home settings.
They also concluded that ‘there is an urgent need for improved and equitable practice for all people with bladder and bowel problems’ through the development of commissioning frameworks, evidence-based training for health professionals and patient empowerment to increase their expectations of cure.
Improving continence care provision through integrated services brings many benefits including:
- a better quality of life and more independence through finding solutions appropriate to individual needs;
- less reliance on pads and products by using alternative treatments;
- a reduction in admissions to hospitals and care homes;
- fewer complications, such as urinary tract infections, faecal impaction and skin breakdown; and
- a reduction in costs.
NHS England’s Excellence in Continence Care guidance provides a framework that enables commissioners to work in collaboration with providers and others to make a step change to address shortfalls so that safe, dignified, efficient and effective continence care is consistently provided.
This guidance is aimed at commissioners, providers, health and social care staff and as information for the public and has been produced in partnership with patient and public advocates, clinicians and partners from the third sector. The roles of everyone involved in the care of people with continence needs are made clear in the guidance and publication via a launch is planned for ‘Self Care Week’ beginning 16 November. The launch will both raise awareness and promote understanding.
In addition the National Institute for Health and Care Excellence has produced a range of guidance for clinicians to support them in the diagnosis, treatment care and support and people with continence problems e.g. Urinary incontinence in women (September 2013), Faecal incontinence in adults (June 2007), Urinary incontinence in neurological disease: assessment and management (August 2012) and Lower urinary tract symptoms in men: management (May 2010).
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment his Department has made of the effectiveness of the Anti-PD-L1 drug in treating bladder cancer.
Answered by George Freeman
Two Anti-PD monoclonal antibody products are being evaluated in clinical trials for various cancers, including bladder cancer.
MPDL3280A, an anti-PD-L1 antibody made by Roche/Genentech, is undergoing a phase I trial (NCT01375842) in patients with locally advanced or metastatic solid tumours. The estimated study completion date is November 2016. The product is also being tested in a phase II trial in in patients with locally advanced or metastatic urothelial bladder cancer (NCT02108652). The estimated completion date for this Phase II trial is January 2016.
The second anti-PD antibody is Nivolumab produced by Bristol-Myers Squibb. Nivolumab on its own, or in combination with another monoclonal antibody ipilimumab (Yervoy®), is in a phase I/II trial in several cancers, including bladder cancer (NCT01928394). This trial is expected to be completed by March 2017.
No assessment of the data from any of these trials has been made to date.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps he is taking to promote awareness of bladder cancer to people under the age of 55.
Answered by Jane Ellison
Public Health England’s Be Clear on Cancer “Blood in Pee” campaign to raise awareness of the main symptom of bladder and kidney cancer targets people over the age of 50, as both of these cancers are more prevalent in people over that age. The campaign uses a wide range of media, including national television and radio advertising, to promote the key message “If you notice blood in your pee, even if it’s just the once, tell your doctor” and while this is targeted to an audience aged 50+ it is very likely that it will also be seen by the wider population.
The “Blood in Pee” campaign has run twice at a national level, following successful local and regional pilots. The national campaign ran in October – November 2013 and October – November 2014.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps he is taking to ensure that people with motor neurone disease have appropriate access to support and equipment in order for their communication needs to be met.
Answered by Norman Lamb
Since 1 April 2013 NHS England has been responsible for commissioning Alternative and Augmentative Communication (AAC) aids for patients with complex disability whose needs require specialised assessment, including for patients with motor neurone disease. Commissioning of non-specialised AAC aids is the responsibility of local clinical commissioning groups.
NHS England has identified an additional £22.5 million funding for AAC and Environmental Controls in 2014-15. A process to identify appropriate providers, and ensure they were able to meet the AAC service specification and standards began in April this year as soon as the budget was confirmed. The specification can be found at:
www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf
The identification of providers was completed in August, and just under £15 million specifically for AAC was transferred to Local Area Team commissioners to agree contracts. During this process, NHS England worked closely with the Motor Neurone Disease Association to ensure that funding was equitably distributed in a fair and consistent manner. The 13 AAC providers selected are in the process of recruiting the required additional specialist therapy staff. Services are already accepting referrals and patients are being prioritised according to their clinical need, with priority being given to patients with life limiting conditions.
Asked by: Glyn Davies (Conservative - Montgomeryshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, how many patients resident in Wales are registered with GPs in England; and how many patients resident in England are registered with GPs in Wales.
Answered by Jane Ellison
As of 16 November 2014, 20,795 patients in England were registered with a Welsh Practice.
As of 4 November 2014, 14,832 patients in Wales were registered with an English Practice.
Source: Regular NHAIS System capitation extracts.